Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 12:16:834058.
doi: 10.3389/fnins.2022.834058. eCollection 2022.

Virus-Induced Maternal Immune Activation as an Environmental Factor in the Etiology of Autism and Schizophrenia

Affiliations
Review

Virus-Induced Maternal Immune Activation as an Environmental Factor in the Etiology of Autism and Schizophrenia

Aïcha Massrali et al. Front Neurosci. .

Erratum in

Abstract

Maternal immune activation (MIA) is mediated by activation of inflammatory pathways resulting in increased levels of cytokines and chemokines that cross the placental and blood-brain barriers altering fetal neural development. Maternal viral infection is one of the most well-known causes for immune activation in pregnant women. MIA and immune abnormalities are key players in the etiology of developmental conditions such as autism, schizophrenia, ADHD, and depression. Experimental evidence implicating MIA in with different effects in the offspring is complex. For decades, scientists have relied on either MIA models or human epidemiological data or a combination of both. MIA models are generated using infection/pathogenic agents to induce an immunological reaction in rodents and monitor the effects. Human epidemiological studies investigate a link between maternal infection and/or high levels of cytokines in pregnant mothers and the likelihood of developing conditions. In this review, we discuss the importance of understanding the relationship between virus-mediated MIA and neurodevelopmental conditions, focusing on autism and schizophrenia. We further discuss the different methods of studying MIA and their limitations and focus on the different factors contributing to MIA heterogeneity.

Keywords: LPS; Poly(I:C); SARS-CoV-2; autism; autism spectrum conditions; maternal immune activation (MIA); schizophrenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Al-Ayadhi L. Y., Mostafa G. A. (2012). Elevated serum levels of interleukin-17A in children with autism. J. .Neuroinflam. 9:158. 10.1186/1742-2094-9-158 - DOI - PMC - PubMed
    1. Ayhan Y., McFarland R., Pletnikov M. V. (2016). Animal models of gene-environment interaction in schizophrenia: A dimensional perspective. Prog. Neurobiol. 136 1–27. 10.1016/j.pneurobio.2015.10.002 - DOI - PMC - PubMed
    1. Baines K. J., Hillier D. M., Haddad F. L., Rajakumar N., Schmid S., Renaud S. J. (2020). Maternal Immune Activation Alters Fetal Brain Development and Enhances Proliferation of Neural Precursor Cells in Rats. Front. Immunol. 11:1145. 10.3389/fimmu.2020.01145 - DOI - PMC - PubMed
    1. Barr C. E., Mednick S. A., Munk-Jorgensen P. (1990). Exposure to Influenza Epidemics During Gestation and Adult Schizophrenia: A 40-Year Study. Arch. General Psych. 47 869–874. 10.1001/archpsyc.1990.01810210077012 - DOI - PubMed
    1. Bauman M. D., Iosif A.-M., Ashwood P., Braunschweig D., Lee A., Schumann C. M., et al. (2013). Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey. Transl. Psych. 3:e278. 10.1038/tp.2013.47 - DOI - PMC - PubMed